Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T52624 Target Info
Target Name Platelet-derived growth factor receptor (PDGFR)
Synonyms Platelet-derived growth factor receptor tyrosine kinase; PDGFR kinase; PDGF-R
Target Type Successful Target
Gene Name NO-GeName
UniProt ID
NOUNIPROTAC
Patent(s) and the Corresponding Patented Drug(s)  Top
World Intellectual Property Organization (WIPO)
Patent ID WO2014132220
Title Solid forms of Bicyclic Heterocyclic Derivatives As Pdgf Receptor Mediators.
Abstract The present invention provides novel solid forms of pharmaceutically active agents and therapeutic uses thereof. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Applicant(s) Novartis Ag
Representative Drug(s) D0Z4QJ Drug Info IC50 = 3 nM Click to Show More [1]
References  Top
REF 1 Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension.Expert Opin Ther Pat. 2015 Apr;25(4):493-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.